BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32296467)

  • 1. Nervous system: Embryonal tumors: Neuroblastoma.
    Pudela C; Balyasny S; Applebaum MA
    Atlas Genet Cytogenet Oncol Haematol; 2020 Jul; 24(7):284-290. PubMed ID: 32296467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent insights into the biology of neuroblastoma.
    Schleiermacher G; Janoueix-Lerosey I; Delattre O
    Int J Cancer; 2014 Nov; 135(10):2249-61. PubMed ID: 25124476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal primary neuroblastoma tumor heterogeneity in siblings with co-occurring PHOX2B and NF1 genetic aberrations.
    Rybinski B; Wolinsky T; Brohl A; Moerdler S; Reed DR; Ewart M; Weiser D
    Genes Chromosomes Cancer; 2020 Feb; 59(2):119-124. PubMed ID: 31515834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
    Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
    Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.
    Van Roy N; De Preter K; Hoebeeck J; Van Maerken T; Pattyn F; Mestdagh P; Vermeulen J; Vandesompele J; Speleman F
    Genome Med; 2009 Jul; 1(7):74. PubMed ID: 19638189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma.
    Deyell RJ; Attiyeh EF
    Cancer Genet; 2011 Mar; 204(3):113-21. PubMed ID: 21504710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and Genetic Features of Neuroblastoma and Their Clinical Importance.
    Aygun N
    Curr Pediatr Rev; 2018; 14(2):73-90. PubMed ID: 29380702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations.
    Bosse KR; Maris JM
    Cancer; 2016 Jan; 122(1):20-33. PubMed ID: 26539795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma.
    Nakagawara A; Li Y; Izumi H; Muramori K; Inada H; Nishi M
    Jpn J Clin Oncol; 2018 Mar; 48(3):214-241. PubMed ID: 29378002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma.
    Oldridge DA; Truong B; Russ D; DuBois SG; Vaksman Z; Mosse YP; Diskin SJ; Maris JM; Matthay KK
    J Natl Cancer Inst; 2019 Nov; 111(11):1192-1201. PubMed ID: 30793172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic alterations in neuroblastoma and their usefulness for clinical management].
    Normand C; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
    Bull Cancer; 2011 May; 98(5):477-88. PubMed ID: 21609891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Basis and Clinical Features of Neuroblastoma.
    Takita J
    JMA J; 2021 Oct; 4(4):321-331. PubMed ID: 34796286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome and transcriptome analysis of neuroblastoma advanced diagnosis from innovative therapies.
    Coco S; Tonini GP; Stigliani S; Scaruffi P
    Curr Pharm Des; 2009; 15(4):448-55. PubMed ID: 19199972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicines and cell-based therapies for embryonal tumors of the nervous system.
    El Moukhtari SH; Garbayo E; Fernández-Teijeiro A; Rodríguez-Nogales C; Couvreur P; Blanco-Prieto MJ
    J Control Release; 2022 Aug; 348():553-571. PubMed ID: 35705114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Predisposition to Neuroblastoma.
    Barr EK; Applebaum MA
    Children (Basel); 2018 Aug; 5(9):. PubMed ID: 30200332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phox2B correlates with MYCN and is a prognostic marker for neuroblastoma development.
    Ke XX; Zhang D; Zhao H; Hu R; Dong Z; Yang R; Zhu S; Xia Q; Ding HF; Cui H
    Oncol Lett; 2015 Jun; 9(6):2507-2514. PubMed ID: 26137098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic susceptibility to neuroblastoma: current knowledge and future directions.
    Ritenour LE; Randall MP; Bosse KR; Diskin SJ
    Cell Tissue Res; 2018 May; 372(2):287-307. PubMed ID: 29589100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization.
    Altura RA; Maris JM; Li H; Boyett JM; Brodeur GM; Look AT
    Genes Chromosomes Cancer; 1997 Jul; 19(3):176-84. PubMed ID: 9218999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic susceptibility to neuroblastoma.
    Tolbert VP; Coggins GE; Maris JM
    Curr Opin Genet Dev; 2017 Feb; 42():81-90. PubMed ID: 28458126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
    Laureys GG
    Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.